TY - JOUR
AU - Yuniati R
AU - Khrisna MB
AB - <jats:title>Abstract</jats:title>
<jats:p>Leprosy is a disease that is caused by <jats:italic>Mycobacterium leprae</jats:italic> which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction, type 2 reaction and neuritis. Type 1 reaction mainly occurs in BB, BL and BT forms of leprosy and is characterized by exacerbation of preexisting lesions. The therapy of this reaction according to the WHO guideline is corticosteroid therapy. This article will explain several key points related to the corticosteroid therapy in leprosy reversal reactions, including the side effects and alternative therapies available.</jats:p>
BT - Serbian Journal of Dermatology and Venereology
DO - 10.2478/sjdv-2019-0011
IS - 3
N2 - <jats:title>Abstract</jats:title>
<jats:p>Leprosy is a disease that is caused by <jats:italic>Mycobacterium leprae</jats:italic> which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction, type 2 reaction and neuritis. Type 1 reaction mainly occurs in BB, BL and BT forms of leprosy and is characterized by exacerbation of preexisting lesions. The therapy of this reaction according to the WHO guideline is corticosteroid therapy. This article will explain several key points related to the corticosteroid therapy in leprosy reversal reactions, including the side effects and alternative therapies available.</jats:p>
PB - Walter de Gruyter GmbH
PY - 2019
SP - 77
EP - 83
T2 - Serbian Journal of Dermatology and Venereology
TI - Glucocorticoids in Leprosy Reversal reaction
UR - https://www.degruyter.com/view/j/sjdv.2019.11.issue-3/sjdv-2019-0011/sjdv-2019-0011.xml
VL - 11
SN - 2406-0631, 1821-0902
ER -